Pub Date : 2024-01-01Epub Date: 2024-09-05DOI: 10.1080/17460913.2024.2389750
Preeti Maurya, Mohit Kumar, Ravi Jain, Haider Thaer Abdulhameed Almuqdadi, Harshita Singh, Aashima Gupta, Christoph Arenz, Naseem A Gaur, Shailja Singh
Aim: To assess the functional relevance of a putative Major Facilitator Superfamily protein (PF3D7_0210300; 'PfMFSDT') as a drug transporter, using Candida glabrata for orthologous protein expression.Methods: Complementary Determining Sequence encoding PfMFSDT was integrated into the genome of genetically engineered C. glabrata strain MSY8 via homologous recombination, followed by assessing its functional relevance as a drug transporter.Results & conclusion: The modified C. glabrata strain exhibited plasma membrane localization of PfMFSDT and characteristics of an Major Facilitator Superfamily transporter, conferring resistance to antifungals, ketoconazole and itraconazole. The nanomolar inhibitory effects of the drugs on the intra-erythrocytic growth of Plasmodium falciparum highlight their antimalarial properties. This study proposes PfMFSDT as a drug transporter, expanding the repertoire of the currently known antimalarial 'resistome'.
{"title":"Expression of <i>Plasmodium</i> major facilitator superfamily protein in transporters - Δ <i>Candida</i> identifies a drug transporter.","authors":"Preeti Maurya, Mohit Kumar, Ravi Jain, Haider Thaer Abdulhameed Almuqdadi, Harshita Singh, Aashima Gupta, Christoph Arenz, Naseem A Gaur, Shailja Singh","doi":"10.1080/17460913.2024.2389750","DOIUrl":"10.1080/17460913.2024.2389750","url":null,"abstract":"<p><p><b>Aim:</b> To assess the functional relevance of a putative Major Facilitator Superfamily protein (PF3D7_0210300; '<i>Pf</i>MFSDT') as a drug transporter, using <i>Candida glabrata</i> for orthologous protein expression.<b>Methods:</b> Complementary Determining Sequence encoding <i>Pf</i>MFSDT was integrated into the genome of genetically engineered <i>C. glabrata</i> strain MSY8 via homologous recombination, followed by assessing its functional relevance as a drug transporter.<b>Results & conclusion:</b> The modified <i>C. glabrata</i> strain exhibited plasma membrane localization of <i>Pf</i>MFSDT and characteristics of an Major Facilitator Superfamily transporter, conferring resistance to antifungals, ketoconazole and itraconazole. The nanomolar inhibitory effects of the drugs on the intra-erythrocytic growth of <i>Plasmodium falciparum</i> highlight their antimalarial properties. This study proposes <i>Pf</i>MFSDT as a drug transporter, expanding the repertoire of the currently known antimalarial 'resistome'.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-09-03DOI: 10.1080/17460913.2024.2386867
Hui Huang, Ting Zhou, Feng He, Biao Wen, Ying Yang, Wei Zhong, Qiurong Wang, Jun Li
Aim: To explore the complex relationship between gut microbiota, obesity-related male reproductive impairments, and the NLRP3 inflammasome.Methods: A high-fat diet was administered to induce obesity in a mouse model, fecal microbiota transplantation or a high-dietary fiber diet (HDFD) was administered for 5 weeks to evaluate changes in parameters related to reproductive capacity, NLRP3, gut microbiota composition and metabolites in mice.Results: A high-fat diet induces obesity and decreases reproductive capacity in male mice. Fecal microbiota transplantation and HDFD can improve reproductive capacity in obese mice by adjusting the gut microbiota population to suppress the NLRP3/ASC/caspase-1 axis, thereby reducing IL-1β levels.Conclusion: This study offers a potential treatment for obesity-induced reproductive dysfunction by targeting the gut microbiota and the NLRP3 inflammasome pathway.
{"title":"The gut microbiota improves reproductive dysfunction in obese mice by suppressing the NLRP3/ASC/caspase-1 axis.","authors":"Hui Huang, Ting Zhou, Feng He, Biao Wen, Ying Yang, Wei Zhong, Qiurong Wang, Jun Li","doi":"10.1080/17460913.2024.2386867","DOIUrl":"10.1080/17460913.2024.2386867","url":null,"abstract":"<p><p><b>Aim:</b> To explore the complex relationship between gut microbiota, obesity-related male reproductive impairments, and the NLRP3 inflammasome.<b>Methods:</b> A high-fat diet was administered to induce obesity in a mouse model, fecal microbiota transplantation or a high-dietary fiber diet (HDFD) was administered for 5 weeks to evaluate changes in parameters related to reproductive capacity, NLRP3, gut microbiota composition and metabolites in mice.<b>Results:</b> A high-fat diet induces obesity and decreases reproductive capacity in male mice. Fecal microbiota transplantation and HDFD can improve reproductive capacity in obese mice by adjusting the gut microbiota population to suppress the NLRP3/ASC/caspase-1 axis, thereby reducing IL-1β levels.<b>Conclusion:</b> This study offers a potential treatment for obesity-induced reproductive dysfunction by targeting the gut microbiota and the NLRP3 inflammasome pathway.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142119541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2023-10-16DOI: 10.2217/fmb-2022-0155
Izel Ungor, Yiorgos Apidianakis
Pseudomonas aeruginosa requires a significant breach in the host defense to cause an infection. While its virulence factors are well studied, its tropism cannot be explained only by studying its interaction with the host. Why are P. aeruginosa infections so rare in the intestine compared with the lung and skin? There is not enough evidence to claim specificity in virulence factors deployed by P. aeruginosa in each anatomical site, and host physiology differences between the lung and the intestine cannot easily explain the observed differences in virulence. This perspective highlights a relatively overlooked parameter in P. aeruginosa virulence, namely, potential synergies with bacteria found in the human skin and lung, as well as antagonisms with bacteria of the human intestine.
{"title":"Bacterial synergies and antagonisms affecting <i>Pseudomonas aeruginosa</i> virulence in the human lung, skin and intestine.","authors":"Izel Ungor, Yiorgos Apidianakis","doi":"10.2217/fmb-2022-0155","DOIUrl":"10.2217/fmb-2022-0155","url":null,"abstract":"<p><p><i>Pseudomonas aeruginosa</i> requires a significant breach in the host defense to cause an infection. While its virulence factors are well studied, its tropism cannot be explained only by studying its interaction with the host. Why are <i>P. aeruginosa</i> infections so rare in the intestine compared with the lung and skin? There is not enough evidence to claim specificity in virulence factors deployed by <i>P. aeruginosa</i> in each anatomical site, and host physiology differences between the lung and the intestine cannot easily explain the observed differences in virulence. This perspective highlights a relatively overlooked parameter in <i>P. aeruginosa</i> virulence, namely, potential synergies with bacteria found in the human skin and lung, as well as antagonisms with bacteria of the human intestine.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41234667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-02-13DOI: 10.2217/fmb-2023-0218
Sören L Becker, Sophie Schneitler
Tweetable abstract There is an urgent need to consider antiparasitic drugs in global efforts to achieve and implement equitable and sustainable antimicrobial stewardship initiatives worldwide.
{"title":"Antiparasitic stewardship: a call to action.","authors":"Sören L Becker, Sophie Schneitler","doi":"10.2217/fmb-2023-0218","DOIUrl":"10.2217/fmb-2023-0218","url":null,"abstract":"<p><p>Tweetable abstract There is an urgent need to consider antiparasitic drugs in global efforts to achieve and implement equitable and sustainable antimicrobial stewardship initiatives worldwide.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-03-21DOI: 10.2217/fmb-2023-0251
Praveen Belagal
Ophthalmia neonatorum is a microbial contraction, damaging eyesight, occurring largely among neonates. Infants are particularly vulnerable to bacterial infections acquired during birth from infected mothers, especially from Neisseria gonorrhoeae and Chlamydia trachomatis. Over the decades, N. gonorrhoeae is alarmingly developing a resistance to most antibiotics currently prescribed. To counter this challenge, it is imperative to find potent and cost-effective therapeutic agents for prophylaxis and treatment, to which the N. gonorrhoeae cannot easily develop resistance. This review showcases alternate therapies such as antimicrobial-fatty acids, -peptides, -nano-formulations etc., currently evident against N. gonorrhoeae-mediated ophthalmia neonatorum, which remains a major cause of ocular morbidity, blindness and even death among neonates in developing countries.
{"title":"Current alternative therapies for treating drug-resistant <i>Neisseria gonorrhoeae</i> causing ophthalmia neonatorum.","authors":"Praveen Belagal","doi":"10.2217/fmb-2023-0251","DOIUrl":"10.2217/fmb-2023-0251","url":null,"abstract":"<p><p>Ophthalmia neonatorum is a microbial contraction, damaging eyesight, occurring largely among neonates. Infants are particularly vulnerable to bacterial infections acquired during birth from infected mothers, especially from <i>Neisseria gonorrhoeae</i> and <i>Chlamydia trachomatis</i>. Over the decades, <i>N. gonorrhoeae</i> is alarmingly developing a resistance to most antibiotics currently prescribed. To counter this challenge, it is imperative to find potent and cost-effective therapeutic agents for prophylaxis and treatment, to which the <i>N. gonorrhoeae</i> cannot easily develop resistance. This review showcases alternate therapies such as antimicrobial-fatty acids, -peptides, -nano-formulations etc., currently evident against <i>N. gonorrhoeae</i>-mediated ophthalmia neonatorum, which remains a major cause of ocular morbidity, blindness and even death among neonates in developing countries.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-05-03DOI: 10.2217/fmb-2023-0227
Graziele C Alvim, Viviane de C Oliveira, Andréa C Dos Reis, Marco A Schiavon, Marcelo R Pinto, Marcos V da Silva, César P Lepri, Denise T de Castro
Aim: To evaluate the biological and mechanical properties of an adhesive with nanostructured silver vanadate (AgVO3). Materials & methods: Specimens in poly(methyl methacrylate) (PMMA) were treated with Ultra Corega Cream (UCCA) denture adhesive with or without AgVO3. Biofilms of Candida albicans, Candida glabrata and Streptococcus mutans were grown and the viable cells counted. Fluorescence microscopy was used. The viability of the VERO cell and adhesive strength were evaluated. Results: All concentrations of AgVO3 reduced the biofilm formation and showed no cytotoxic effect. At 5 min and 24 h, UCCA with 5 and 10% AgVO3 showed better performance, respectively. Conclusion: AgVO3 promoted the antibiofilm activity of the adhesive, with a positive effect on the adhesive strength, and was biocompatible.
{"title":"Effect of silver vanadate on the antibiofilm, adhesion and biocompatibility properties of denture adhesive.","authors":"Graziele C Alvim, Viviane de C Oliveira, Andréa C Dos Reis, Marco A Schiavon, Marcelo R Pinto, Marcos V da Silva, César P Lepri, Denise T de Castro","doi":"10.2217/fmb-2023-0227","DOIUrl":"10.2217/fmb-2023-0227","url":null,"abstract":"<p><p><b>Aim:</b> To evaluate the biological and mechanical properties of an adhesive with nanostructured silver vanadate (AgVO<sub>3</sub>). <b>Materials & methods:</b> Specimens in poly(methyl methacrylate) (PMMA) were treated with Ultra Corega Cream (UCCA) denture adhesive with or without AgVO<sub>3</sub>. Biofilms of <i>Candida albicans</i>, <i>Candida glabrata</i> and <i>Streptococcus mutans</i> were grown and the viable cells counted. Fluorescence microscopy was used. The viability of the VERO cell and adhesive strength were evaluated. <b>Results:</b> All concentrations of AgVO<sub>3</sub> reduced the biofilm formation and showed no cytotoxic effect. At 5 min and 24 h, UCCA with 5 and 10% AgVO<sub>3</sub> showed better performance, respectively. <b>Conclusion:</b> AgVO<sub>3</sub> promoted the antibiofilm activity of the adhesive, with a positive effect on the adhesive strength, and was biocompatible.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-06-12DOI: 10.2217/fmb-2023-0271
Fatima Daiana Dias Barroso, Lisandra Juvêncio da Silva, Helaine Almeida Queiroz, Lívia Gurgel do Amaral Valente Sá, Anderson Ramos da Silva, Cecília Rocha da Silva, João Batista de Andrade Neto, Bruno Coêlho Cavalcanti, Manoel Odorico de Moraes, Aurora Pinazo, Lourdes Pérez, Hélio Vitoriano Nobre Júnior
Aim: The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant Staphylococcus aureus (MRSA). Methodology: Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. Result: RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. Conclusion: RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant S. aureus biofilms.
{"title":"Biosurfactant complexed with arginine has antibiofilm activity against methicillin-resistant <i>Staphylococcus aureus</i>.","authors":"Fatima Daiana Dias Barroso, Lisandra Juvêncio da Silva, Helaine Almeida Queiroz, Lívia Gurgel do Amaral Valente Sá, Anderson Ramos da Silva, Cecília Rocha da Silva, João Batista de Andrade Neto, Bruno Coêlho Cavalcanti, Manoel Odorico de Moraes, Aurora Pinazo, Lourdes Pérez, Hélio Vitoriano Nobre Júnior","doi":"10.2217/fmb-2023-0271","DOIUrl":"10.2217/fmb-2023-0271","url":null,"abstract":"<p><p><b>Aim:</b> The present study investigated the antimicrobial effectiveness of a rhamnolipid complexed with arginine (RLMIX_Arg) against planktonic cells and biofilms of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). <b>Methodology:</b> Susceptibility testing was performed using the Clinical & Laboratory Standards Institute protocol: M07-A10, checkerboard test, biofilm in plates and catheters and flow cytometry were used. <b>Result:</b> RLMIX_Arg has bactericidal and synergistic activity with oxacillin. RLMIX_Arg inhibits the formation of MRSA biofilms on plates at sub-inhibitory concentrations and has antibiofilm action against MRSA in peripheral venous catheters. Catheters impregnated with RLMIX_Arg reduce the formation of MRSA biofilms. <b>Conclusion:</b> RLMIX_Arg exhibits potential for application in preventing infections related to methicillin-resistant <i>S. aureus</i> biofilms.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-05-24DOI: 10.1080/17460913.2024.2344953
Lucia Corich, Carmen Losasso, Alessia Meneghel, Francesca Irene Blarasin, Giancarlo Basaglia, Maria Ada Corich
Non-diphtheroid Corynebacterium sepsis is rare and has affected only immunocompromised or particularly predisposed patients so far. We present the first case of urosepsis caused by Corynebacterium aurimucosum in a 67-year-old woman, without any known immunodeficiencies and in absence of any immunosuppressive therapy, admitted to the hospital for fever and acute dyspnea. This work suggests a new approach in evaluating the isolation of Corynebacteria, especially if isolated from blood. In particular, it highlights the potential infectious role of C. aurimucosum (often considered a contaminant and only rarely identified as an etiological agent of infections) and its clinical consequences, detailing also interesting aspects about its microbiological diagnosis and relative therapy and clarifying contrasting data of literature.
非二白喉科里纳菌败血症非常罕见,迄今为止只有免疫力低下或特别易感的患者才会患上这种疾病。我们介绍了首例由琥珀色棒状杆菌(Corynebacterium aurimucosum)引起的尿毒症病例,患者是一名 67 岁的女性,无任何已知的免疫缺陷,也未接受任何免疫抑制治疗,因发热和急性呼吸困难入院。这项研究提出了一种新的方法来评估棒状杆菌的分离,尤其是从血液中分离出来的棒状杆菌。特别是,它强调了 C. aurimucosum(通常被认为是一种污染物,很少被确定为感染的病原体)的潜在感染作用及其临床后果,还详细介绍了其微生物学诊断和相关治疗的有趣方面,并澄清了文献中的对比数据。
{"title":"The first case of urosepsis caused by <i>Corynebacterium aurimucosum</i> in an immunocompetent patient.","authors":"Lucia Corich, Carmen Losasso, Alessia Meneghel, Francesca Irene Blarasin, Giancarlo Basaglia, Maria Ada Corich","doi":"10.1080/17460913.2024.2344953","DOIUrl":"10.1080/17460913.2024.2344953","url":null,"abstract":"<p><p>Non-diphtheroid <i>Corynebacterium</i> sepsis is rare and has affected only immunocompromised or particularly predisposed patients so far. We present the first case of urosepsis caused by <i>Corynebacterium aurimucosum</i> in a 67-year-old woman, without any known immunodeficiencies and in absence of any immunosuppressive therapy, admitted to the hospital for fever and acute dyspnea. This work suggests a new approach in evaluating the isolation of <i>Corynebacteria</i>, especially if isolated from blood. In particular, it highlights the potential infectious role of <i>C. aurimucosum</i> (often considered a contaminant and only rarely identified as an etiological agent of infections) and its clinical consequences, detailing also interesting aspects about its microbiological diagnosis and relative therapy and clarifying contrasting data of literature.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-07-29DOI: 10.1080/17460913.2024.2381967
Joya-Rita Hindy, Tarek Souaid, Christopher S Kovacs
Aim: Assessing the visual accuracy of two large language models (LLMs) in microbial classification.Materials & methods: GPT-4o and Gemini 1.5 Pro were evaluated in distinguishing Gram-positive from Gram-negative bacteria and classifying them as cocci or bacilli using 80 Gram stain images from a labeled database.Results: GPT-4o achieved 100% accuracy in identifying simultaneously Gram stain and shape for Clostridium perfringens, Pseudomonas aeruginosa and Staphylococcus aureus. Gemini 1.5 Pro showed more variability for similar bacteria (45, 100 and 95%, respectively). Both LLMs failed to identify both Gram stain and bacterial shape for Neisseria gonorrhoeae. Cumulative accuracy plots indicated that GPT-4o consistently performed equally or better in every identification, except for Neisseria gonorrhoeae's shape.Conclusion: These results suggest that these LLMs in their unprimed state are not ready to be implemented in clinical practice and highlight the need for more research with larger datasets to improve LLMs' effectiveness in clinical microbiology.
{"title":"Capabilities of GPT-4o and Gemini 1.5 Pro in Gram stain and bacterial shape identification.","authors":"Joya-Rita Hindy, Tarek Souaid, Christopher S Kovacs","doi":"10.1080/17460913.2024.2381967","DOIUrl":"10.1080/17460913.2024.2381967","url":null,"abstract":"<p><p><b>Aim:</b> Assessing the visual accuracy of two large language models (LLMs) in microbial classification.<b>Materials & methods:</b> GPT-4o and Gemini 1.5 Pro were evaluated in distinguishing Gram-positive from Gram-negative bacteria and classifying them as cocci or bacilli using 80 Gram stain images from a labeled database.<b>Results:</b> GPT-4o achieved 100% accuracy in identifying simultaneously Gram stain and shape for <i>Clostridium perfringens</i>, <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>. Gemini 1.5 Pro showed more variability for similar bacteria (45, 100 and 95%, respectively). Both LLMs failed to identify both Gram stain and bacterial shape for <i>Neisseria gonorrhoeae</i>. Cumulative accuracy plots indicated that GPT-4o consistently performed equally or better in every identification, except for <i>Neisseria gonorrhoeae's</i> shape.<b>Conclusion:</b> These results suggest that these LLMs in their unprimed state are not ready to be implemented in clinical practice and highlight the need for more research with larger datasets to improve LLMs' effectiveness in clinical microbiology.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141787811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01Epub Date: 2024-09-11DOI: 10.1080/17460913.2024.2392454
Abozar Nasiri-Jahrodi, Mehdi Barati, Fatemeh-Maryam Sheikholeslami, Mona Fani, Azin Nikoozadeh
This study reports the first case of lung and fungus ball lesions caused by Cladosporium subcinereum A48. A rural diabetic woman infected by C. subcinereum A48, presented with fever and hemoptysis. CT scans, bronchoalveolar lavage, culture and molecular methods were used to evaluate and confirm the disease. Our patient had not taken insulin during the last few months of her life which probably caused acidosis and a decrease in the patient's immunity level, resulting in penetration and formation of a fungal in the lung.
{"title":"A case of lung and fungus ball lesions associated with <i>Cladosporium Subcinereum A48</i> in a diabetic patient.","authors":"Abozar Nasiri-Jahrodi, Mehdi Barati, Fatemeh-Maryam Sheikholeslami, Mona Fani, Azin Nikoozadeh","doi":"10.1080/17460913.2024.2392454","DOIUrl":"10.1080/17460913.2024.2392454","url":null,"abstract":"<p><p>This study reports the first case of lung and fungus ball lesions caused by <i>Cladosporium subcinereum A48</i>. A rural diabetic woman infected by <i>C. subcinereum A48</i>, presented with fever and hemoptysis. CT scans, bronchoalveolar lavage, culture and molecular methods were used to evaluate and confirm the disease. Our patient had not taken insulin during the last few months of her life which probably caused acidosis and a decrease in the patient's immunity level, resulting in penetration and formation of a fungal in the lung.</p>","PeriodicalId":12773,"journal":{"name":"Future microbiology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142284400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}